XAIR Stock Forecast: Beyond Air, Inc. Price Predictions for 2026-2027
The median 12-month analyst price target for Beyond Air, Inc. is $20. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 32 of 100 as at 21 Nov 2026 — in the lower half.
One number for the whole business
Consensus tells you what everyone already believes. The model scores Beyond Air, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Accruals (80): Reported profit is backed by cash, and the company is not expanding recklessly.
Momentum (3): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
XAIR stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on XAIR, reported as data — targets and ratings, the market's view beside the model's.
We don’t hold enough price history for this company yet.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 1 Sept 2026 | Lake Street | Initiates | Buy | $10 |
| 27 Mar 2026 | D. Boral Capital | Maintains | Buy | $10 |
| 18 Mar 2026 | D. Boral Capital | Maintains | Buy | — |
| 10 Mar 2026 | D. Boral Capital | Maintains | Buy | — |
| 21 Jan 2026 | D. Boral Capital | Maintains | Buy | — |
| 11 Nov 2025 | D. Boral Capital | Maintains | Buy | — |
| 21 Aug 2025 | D. Boral Capital | Maintains | Buy | — |
| 13 Aug 2025 | D. Boral Capital | Maintains | Buy | — |
| 17 July 2025 | D. Boral Capital | Initiates | Buy | — |
| 16 Aug 2024 | Roth MKM | Reinstates | Buy | $2.00 |
| 7 Aug 2024 | Piper Sandler | Maintains | Overweight | — |
| 25 June 2024 | BTIG | Downgrade | Neutral | — |
| 25 June 2024 | Piper Sandler | Maintains | Overweight | — |
| 30 Apr 2024 | Truist Securities | Maintains | Buy | — |
| 14 Nov 2023 | Truist Securities | Maintains | Buy | — |
| 28 July 2023 | Piper Sandler | Initiates | Overweight | — |
| 21 July 2023 | Truist Securities | Maintains | Buy | — |
| 23 June 2023 | Oppenheimer | Maintains | Outperform | — |
| 15 June 2023 | BTIG | Initiates | Buy | — |
| 29 June 2022 | Ladenburg Thalmann | Maintains | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for XAIR.
This page is one stock. Monday covers all of them.
XAIR appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
XAIR analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- 0.3×
- Price / book
- 0.2×
- EV / EBITDA
- —
Cheaper than 85% of US stocks
Cheaper than 95% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- 12.7%
- Operating margin
- —
- Net margin
- —
Higher than 12% of US stocks
- Return on equity
- −357.2%
- Return on assets
- −49.0%
- Dividend yield
- —
Higher than 4% of US stocks
Higher than 8% of US stocks
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Beyond Air, Inc. has a market value of $2.9M and an enterprise value of $16.5M.
Revenue in the twelve months to 30 June 2026: $7.7M. The latest quarter grew 0.5% year on year.
Net income over the same four quarters: −$34.4M, a −447.6% net margin.
Diluted earnings per share, trailing twelve months: −$277.40.
Free cash flow in the twelve months to 30 June 2026: −$19.6M.
Beyond Air, Inc. employs 54 people — $142K of revenue per employee.
Data provided by Twelve Data
XAIR and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at XAIR’s peer groups, ranked by the model: healthcare stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own Beyond Air, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about XAIR
What is the XAIR stock price forecast for 2026-2027?
The median 12-month analyst price target for Beyond Air, Inc. is $20, with estimates ranging from $10 to $30. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is XAIR stock a buy right now?
Of the 2 analysts covering Beyond Air, Inc., 2 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Beyond Air, Inc. 32 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank XAIR?
As at 21 Nov 2026, Beyond Air, Inc. ranks 32 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Accruals (80 of 100).
Will XAIR stock go up?
No one can know that. What the data says: the median 12-month target from 2 analysts is $20, and Ticker Nerd's factor model ranks Beyond Air, Inc. 32 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the XAIR stock forecast for 2030?
No analyst covering Beyond Air, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for XAIR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $10 to $30 over the next 12 months.
What does Beyond Air, Inc. do?
Beyond Air Inc. is a commercial-stage medical device and biopharmaceutical company focused on nitric oxide-based therapies and delivery systems. The company’s core LungFit platform generates nitric oxide from ambient air and delivers it in a controlled way for respiratory care, with applications centered on neonatal respiratory conditions and other serious lung diseases.
About Beyond Air, Inc.
Beyond Air Inc. is a commercial-stage medical device and biopharmaceutical company focused on nitric oxide-based therapies and delivery systems. The company’s core LungFit platform generates nitric oxide from ambient air and delivers it in a controlled way for respiratory care, with applications centered on neonatal respiratory conditions and other serious lung diseases. Beyond Air also operates development programs aimed at extending its nitric oxide technology across additional respiratory, neurological, and oncology-related uses. Its business is organized around Beyond Air, Beyond Cancer, and NeuroNos, reflecting a broader platform approach that combines device engineering with therapeutic development. Headquartered in Garden City, New York, Beyond Air serves the healthcare market through products and programs designed for hospital-based clinical use and specialized medical treatment settings.
CEO Mr. Robert Scott Goodman · 54 employees · United States · https://www.beyondair.net